Registry for pregnancy outcomes after Exablate treatment for uterine fibroids

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational registry study aims to collect data on clinical pregnancy outcomes and treatment backgrounds for individuals who have undergone Exablate treatment for symptomatic uterine fibroids. Participants will be monitored for two years post-treatment to assess the impact of the Exablate procedure on pregnancy occurrences. The study is designed to gather safety data and inform potential updates to labeling regarding the treatment's effects on fertility.

Why it matters

Who can join: the full rules

Inclusion Criteria: - - Eligibility is as per the symptomatic fibroids device indication. - All registry-consented patients following the treatment of their fibroid(s) with the Exablate system. Exclusion Criteria: -

Where it's running

• UCLA
  Los Angeles, California, United States Recruiting
• Stanford University
  Stanford, California, United States Recruiting
• Mayo Clinic
  Rochester, Minnesota, United States Recruiting
• Shanghai No. 1 Hospital
  Shanghai, China Recruiting
• Shanghai No.1 Hospital
  Shanghai, China Recruiting
• Huashan Hospital Affiliated to Fudan University
  Shanghai, China Active not recruiting

Study contacts

• Study coordinator: Nadir Alikacem
• Email: nadira@insightec.com
• Phone: +12146302000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Relugolix (Ryeqo) with low‑dose add-back hormones for uterine fibroids and endometriosis and its effects on blood clotting

  This trial will test whether the GnRH antagonist Relugolix combined with low‑dose estradiol and progestin (Ryeqo) changes blood clotting markers in adult women treated for uterine fibroids or endometriosis.

  Recruiting University Hospital, Geneva · Geneva, Canton of Geneva · NCT07173127

• Evaluating uterine fibroids using ultrasound techniques before and after treatment

  This study is testing if a special ultrasound can help women with uterine fibroids see how their condition changes before and after a specific treatment called uterine artery embolization.

  Recruiting Phase 2 Thomas Jefferson University · Philadelphia, Pennsylvania · NCT06705075

• Using Bearing nsPVA particles for treating uterine fibroids

  This study is testing if a new type of particles used in a procedure can safely help women with painful uterine fibroids feel better.

  Recruiting at 3 sites Merit Medical Systems, Inc. · Brooklyn, New York and 3 other locations · NCT06153667

• Impact of Uterine Fibroids on Women's Fertility

  This study looks at how uterine fibroids might affect pregnancy rates in women aged 20-50 who are struggling with infertility.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT06020924

• Uterine Fibroids in China: How Common They Are and What Increases Risk

  This study tests how common uterine fibroids are in Chinese women and what factors relate to developing them and needing surgery.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT05840042

• Vitamin D3 for symptomatic uterine fibroids in women with vitamin D deficiency

  This trial will try giving vitamin D3 for six months to women with symptomatic uterine fibroids and low vitamin D to see if their symptoms and fibroid size improve.

  Recruiting at 2 sites Early Phase 1 Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh · Dhaka, Sahabag and 1 other locations · NCT07012161

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.